Riccardo Ricotta Selected Research

Riccardo Ricotta Research Topics

Disease

13	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 10/2011
11	Neoplasms (Cancer) 01/2022 - 01/2006
7	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 03/2004
4	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 11/2004
2	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2005
2	Colonic Neoplasms (Colon Cancer) 10/2021 - 05/2008
2	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2015
1	Cardiotoxicity 01/2022
1	Inflammation (Inflammations) 01/2021
1	Urogenital Neoplasms 01/2021
1	Clear-cell metastatic renal cell carcinoma 06/2015
1	Carcinogenesis 03/2014
1	Disease Progression 09/2007
1	Neutropenia 12/2006
1	Infections 12/2006
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2006
1	Carcinoma (Carcinomatosis) 11/2004

Drug/Important Bio-Agent (IBA)

4	cabozantinibIBA 10/2020 - 01/2018
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2014
3	regorafenibIBA 01/2016 - 05/2013
2	Hemoglobins (Hemoglobin)IBA 12/2019 - 06/2015
2	Everolimus FDA Link 01/2018 - 01/2018
2	Sunitinib (Sutent)FDA Link 01/2018 - 10/2011
2	Pharmaceutical PreparationsIBA 01/2017 - 06/2016
2	Docetaxel (Taxotere)FDA Link 06/2016 - 07/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	thiazolyl blueIBA 01/2022
1	WastewaterIBA 01/2022
1	PolyphenolsIBA 01/2022
1	AnthracyclinesIBA 01/2022
1	Olive OilIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	AntimetabolitesIBA 01/2022
1	Tissue Inhibitor of Metalloproteinase-1IBA 10/2021
1	CytokinesIBA 10/2021
1	Conditioned Culture MediaIBA 10/2021
1	Tissue Inhibitor of Metalloproteinase-2IBA 10/2021
1	Metalloproteases (Metalloproteinases)IBA 10/2021
1	CeramidesIBA 01/2021
1	ElementsIBA 01/2021
1	NivolumabIBA 01/2021
1	mesoglycanIBA 01/2020
1	Axitinib (AG 013736)IBA 01/2018
1	abirateroneIBA 06/2016
1	Phosphotransferases (Kinase)IBA 05/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2016
1	enzalutamideIBA 07/2015
1	cabazitaxel FDA Link 07/2015
1	Abiraterone AcetateIBA 07/2015
1	nasIBA 07/2015
1	pazopanib FDA Link 05/2014
1	Growth Factor ReceptorsIBA 03/2014
1	Angiopoietin-1IBA 03/2014
1	Protein Kinases (Protein Kinase)IBA 03/2014
1	Panitumumab (Vectibix)FDA Link 03/2013
1	Cetuximab (Erbitux)FDA Link 03/2013
1	Indicators and Reagents (Reagents)IBA 03/2013
1	ErbB Receptors (EGF Receptor)IBA 03/2013
1	Sorafenib (BAY 43-9006)FDA Link 10/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2006
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2006
1	pegfilgrastim (Neulasta)FDA Link 12/2006
1	Filgrastim (Neupogen)FDA Link 12/2006
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 12/2006
1	Biological ProductsIBA 01/2006
1	Capecitabine (Xeloda)FDA Link 04/2005
1	Hormones (Hormone)IBA 11/2004
1	AndrogensIBA 11/2004
1	raltitrexed (D 1694)IBA 03/2004
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2004

Therapy/Procedure

12	Therapeutics 01/2022 - 11/2004
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2004
2	Castration 06/2016 - 07/2015
1	Immunotherapy 01/2021
1	Precision Medicine 01/2021
1	Treatment Delay 01/2019
1	Aftercare (After-Treatment) 01/2018
1	Palliative Care (Palliative Therapy) 05/2008
1	Injections 12/2006
1	Radiotherapy 11/2004